🇩🇪 Germany Country × Condition
acute kidney injury Clinical Trials in Germany
Active clinical trials for acute kidney injury with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇩🇪 Germany
Active Trials in Germany (4)
NCT06180551
Recruiting
Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis
Enrollment
1,000 pts
Country
🇩🇪 Germany
Universität des Saarlandes
View Trial → NCT06291714
Recruiting
Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension
Enrollment
150 pts
Country
🇩🇪 Germany
University of Giessen
View Trial → NCT07338669
Recruiting
Hamburg Acute Renal Injury Study (HARIS)
Enrollment
1,000 pts
Country
🇩🇪 Germany
Universitätsklinikum Hamburg-Eppend...
View Trial → NCT05830669
Recruiting
Remote Ischemic Preconditioning in Septic Patients
Enrollment
64 pts
Country
🇩🇪 Germany
Universität Münster
View Trial → Frequently Asked Questions
How many acute kidney injury clinical trials are active in Germany?
There are currently 4 active clinical trials for acute kidney injury with sites in Germany, of which 4 are actively recruiting patients.
How can I join a acute kidney injury clinical trial in Germany?
To join a acute kidney injury clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute kidney injury trials in Germany?
Active acute kidney injury trials in Germany span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology